Rated #1

Medical News

Aspirin May Be More Effective At Preventing Cancer Deaths

Researchers at Oxford reached that conclusion after examining "the cancer death rates of 25,570 patients who had participated in eight different randomized controlled trials of aspirin that ended up to 20 years earlier," the New York Times (12/7, A16, Rabin) reports. "Participants who had been assigned to the aspirin arms of the studies were 20 percent less likely after 20 years to have died of solid tumor cancers than those who had been in the comparison group taking dummy pills during the clinical trials, and their risk of gastrointestinal cancer death was 35 percent lower. The risk of lung cancer death was 30 percent lower, the risk of colorectal cancer death was 40 percent lower, and the risk of esophageal cancer death was 60 percent lower."

SOURCE: Breastcancer.org